Skip to content
NFA-VPS Over the Counter Companion Animal

Veloxa XL Chewable Tablets for Dogs

Active ingredients: Febantel, Praziquantel, Pyrantel

Form

Chewable

Species

Dogs

Manufacturer

Lavet Pharmaceuticals Ltd

VMD MA No.

32823/4011

What it's used for

Ascarids : (adult and late immature forms) Hookworms : (adults) Whipworms : (adults) AN: 01899/2024 & 01900/2024Page 2 of 6 Tapeworms : (adult and immature...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Febantel + Praziquantel + Py...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Clinical information

Veloxa XL Chewable Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Ascarids : (adult and late immature forms)
Hookworms : (adults)
Whipworms : (adults)
AN: 01899/2024 & 01900/2024Page 2 of 6
Tapeworms : (adult and immature
forms).
Dosage
1 chewable tablet per 35 kg bodyweight (15 mg febantel, 5 mg pyrantel (as embonate) and
5 mg praziquantel/kg body weight).
Body weight (kg)Number of chewable tablets17.51/2>17.5 -351>35 -52.51 ½>52.5 -702
Do not use for treatment of dogs weighing less than 17.5 kg (i.e. <17.5 kg).
To ensure administration of a correct dose, body weight should be determined as
accurately as possible.
AN: 01899/2024 & 01900/2024Page 4 of 6
Administration
The chewable tablets can be given directly to the dog or disguised in food. No starvation is
needed before or after treatment.
Due to a lipid-coating of praziquantel and added flavour, the chewable tablets are taken by
most dogs voluntarily.
Duration of Treatment
A single dose shall be used. If there is a risk for re-infestation, the advice of a veterinarian
should be sought regarding the need for and the frequency of repeat administration.
Do not use in animals with a hypersensitivity to any of the active substances or the
excipients.
Dog.
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Digestive tract disorder (e.g., vomiting) *
AN: 01899/2024 & 01900/2024Page 3 of 6
* mild and transient
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder, or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
Fleas serve as intermediate hosts for one common type of tapeworm – Dipylidium
caninum.
Tapeworm infestation is certain to reoccur unless control of intermediate hosts such as
fleas, mice, etc. is undertaken.

Special precautions for safe use in the target species:
Veloxa Chewable Tablets for smaller dogs is recommended for use in dogs less than 17.5
kg bodyweight.
Tapeworm infestation is unlikely in pups less than 6 weeks of age.
The tablets are flavoured. In order to avoid any accidental ingestion, store tablets out of
reach of animals.
To minimise the risk of re-infestation and new infestation, excreta should be collected and
properly disposed of for 24 hours following treatment.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In the interests of good hygiene, persons administering the chewable tablet directly to a
dog or by adding it to the dog’s food, should wash their hands afterwards.
In case of accidental ingestion, seek medical advice immediately and show the package
leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
Other precautions:
Since it contains praziquantel, the veterinary medicinal product is effective against
Echinococcus spp. which do not occur in all EU member states but are becoming more
common in some. Echinococcosis represents a hazard for humans. As Echinococcosis is
a notifiable disease to the World Organisation for Animal Health (WOAH), specific
guidelines on the treatment and follow-up, and on the safeguard of persons, need to be
obtained from the relevant competent authority.
Do not use simultaneously with piperazine as the anthelmintic effects of pyrantel and
piperazine may be antagonized. Concurrent use with other cholinergic compounds can
lead to toxicity.
Plasma concentrations of praziquantel may be decreased by concomitant administration
with drugs that increase the activity of cytochrome P-450 enzymes (e.g. dexamethasone,
phenobarbital).
This veterinary medicinal product does not require any special storage conditions.
Keep the blister in the outer carton. Each time an unused half tablet is stored it should be
returned to the open blister space and the blister inserted back into the outer carton.
Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.